What are the reporting procedures for adverse events following Dukoral vaccination?

Valneva Canada Inc. is focused on the marketing and distribution of Valneva's vaccine DUKORAL®, IXIARO® and KamRAB™. Cholera is an acute, secretory diarrhoea caused by infection with Vibrio cholerae of the O1 or O139 serogroup. It is endemic in more than 50 countries and also ... Detailed product information. How it works. How to use. Ingredients. Warnings. Storage & Other Information ... How do I use the suppository? What does "retain" ... Three oral cholera vaccines (OCVs) are currently pre-qualified by WHO: Dukoral®,. Shanchol™, and Euvichol® All are oral killed whole-cell (WC) vaccines that ... The cholera vaccine can protect patients with inflammatory bowel disease (IBD) against both cholera and travelers' diarrhea. However, both immunosuppressive ... Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google ... ... information about appropriate vaccines and prevention of diarrhea and malaria. Guidelines are also available from the Infectious Diseases... Patients ... For more information, including what to do if you have any side effects, see Section 6. Are there any side effects? in the full CMI. Dukoral®. Active ingredient ... If a bioterrorist event is suspected, IDPH and other response authorities will work closely with LPHA(s) and provide instructions/information on how to proceed. Jan 28, 2025 ... Prices are in effect for those who do not meet the criteria for ... Dukoral™ (Series of two) $130; Dukoral™ (Individual booster) $65 ...